Wellington Management Group’s Avalyn Pharma AVLN Stock Holding History
Bought
Maintained
Sold
Other funds holding AVLN
Wellington Management Group's AVLN Position: Q3 2026 in Review
Wellington Management Group reduced its Avalyn Pharma (AVLN) stake by 4.4% in Q3 2026, selling an estimated $3.13M and leaving 2,104,859 shares worth $60M. The position accounts for 0.01% of the portfolio, ranked #666.
Wellington Management Group first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $72.5M in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.
- Wellington Management Group held 2,104,859 shares of Avalyn Pharma worth $60M as of Q3 2026.
- Wellington Management Group sold 97,127 Avalyn Pharma shares in Q3 2026, an estimated $3.13M.
- Avalyn Pharma made up 0.01% of Wellington Management Group's portfolio in Q3 2026, its #666 holding.
- Wellington Management Group first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
- Wellington Management Group's Avalyn Pharma position peaked at $72.5M in Q2 2026.
- 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.